Bispecific BCMA/CD19 targeted CAR-T cell therapy forces sustained disappearance of symptoms and anti-acetylcholine receptor antibodies in refractory myasthenia gravis: a case report.

Xiaoyu HuangDan LiuZhouao ZhangXiaoyu HuangJiang CaoGang WangXue DuZhouyi WangMingjin YangTiancheng LuoSha LiuWan ZhangYing ShengHuizhong LiWei ZhangHao ChenShenyang ZhangXiaopeng WangWenqing MengShenghua ZongMing ShiJunnian ZhengGuiyun Cui

Published in: Journal of neurology (2024)

Keyphrases

cell therapy
myasthenia gravis
stem cells
mesenchymal stem cells
cancer therapy
nk cells
binding protein
drug delivery
bone marrow
physical activity